Amplification Mechanisms of Lung Endothelial Inflammation During Acute Lung Injury

急性肺损伤期间肺内皮炎症的放大机制

基本信息

  • 批准号:
    10435435
  • 负责人:
  • 金额:
    $ 57.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-01-15 至 2024-12-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY / ABSTRACT Lung failure from endotoxemia and sepsis induces widespread and often rapid lung vascular endothelial injury due to unfettered influx of inflammatory cells such as neutrophils and macrophages. This maladaptive inflammatory response outpaces the reparative capacity of lungs, resulting in profound inflammatory lung injury and hypoxemia. This proposal focuses on fundamental amplification mechanisms underlying the maladaptive inflammatory activation of the lung endothelium. Our central hypothesis is that the inflammatory response to threat signals such as the initial breaching of the endothelial plasma membrane by bacterial lipopolysaccharide (LPS) and rapid release of mitochondrial DNA by the injured mitochondria into the cytosol massively and acutely amplifies the inflammatory response and thus serves as essential feed-forward mechanisms for progression of acute lung injury (ALI). In Aim 1, we will determine the mechanisms by which the recently identified perforin Gasdermin D mediates endothelial plasma membrane pore formation and the mechanisms of activation of the K+ efflux ion channel TWIK2 that we have recently identified. We will address the role of amplifying K+ efflux on the severity and rapidity of endothelial NLRP3 inflammasome activation and fulminant lung injury. In Aim 2, we will define another crucial amplification mechanism, the potentially important role of Gasdermin D-mediated mitochondrial (mt) membrane pore formation and the release of mtDNA, which may also catastrophically amplifiy lung injury via activation of Type I interferon signaling. These mechanistically driven studies will utilize genetic mouse models (endothelial specific knockout models in our labs) as well as comprehensive imaging, electrophysiological and physiological approaches and thus provide the framework for identifying novel endothelial amplification inflammatory mechanisms that induce lung vascular injury and ALI. We will elucidate how these pathways can be targeted to reduce tissue damage and improve survival.
项目总结/摘要 内毒素血症和脓毒症引起的肺衰竭可引起广泛且通常快速的肺血管内皮损伤, 炎症细胞如中性粒细胞和巨噬细胞的不受限制的流入。这种适应不良的炎症 反应速度超过肺的修复能力,导致严重的炎性肺损伤和低氧血症。 这项建议的重点是基础放大机制的适应不良的炎症反应, 激活肺内皮。我们的中心假设是,对威胁的炎症反应发出这样的信号, 由于细菌脂多糖(LPS)最初破坏内皮细胞质膜, 损伤的线粒体大量释放线粒体DNA进入胞质,并急性放大炎症反应。 反应,并因此作为重要的前馈机制的急性肺损伤(ALI)的进展。在Aim中 1,我们将确定最近发现的穿孔素Gasdermin D介导 内皮细胞质膜孔的形成和K+外排离子通道的激活机制 我们最近发现的TWIK 2。我们将讨论放大K+外流对严重性的作用, 内皮NLRP 3炎性体活化和暴发性肺损伤的快速性。在目标2中,我们定义 另一个关键的扩增机制,Gasdermin D介导的潜在重要作用, 线粒体(mt)膜孔的形成和mtDNA的释放,这也可能是灾难性的 通过激活I型干扰素信号传导减轻肺损伤。这些机械驱动的研究将利用 遗传小鼠模型(我们实验室中的内皮特异性敲除模型)以及全面成像, 因此提供了用于鉴定新的内皮细胞的框架, 放大炎症机制,诱导肺血管损伤和ALI。我们将阐明这些 可以靶向这些通路以减少组织损伤并提高存活率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Asrar B. Malik其他文献

Tissue Regeneration Requires Edema Fluid Clearance by Compensatory Lymphangiogenesis in Zebrafish
斑马鱼的组织再生需要通过补偿性淋巴管生成清除水肿液
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Olamide Olayinka;Hannah Ryu;Xiaowei Wang;Asrar B. Malik;Hyun Min Jung
  • 通讯作者:
    Hyun Min Jung
H<sub>2</sub>O<sub>2</sub> and Tumor Necrosis Factor-α Activate Intercellular Adhesion Molecule 1 (ICAM-1) Gene Transcription through Distinct <em>cis</em>-Regulatory Elements within the ICAM-1 Promoter
  • DOI:
    10.1074/jbc.270.32.18966
  • 发表时间:
    1995-08-11
  • 期刊:
  • 影响因子:
  • 作者:
    Kenneth A. Roebuck;Arshad Rahman;Venkatesh Lakshminarayanan;Kilambi Janakidevi;Asrar B. Malik
  • 通讯作者:
    Asrar B. Malik
Functional role of TRPC channels in the regulation of endothelial permeability
Compensatory lymphangiogenesis is required for edema resolution in zebrafish
补偿性淋巴管生成是斑马鱼水肿消退所必需的
  • DOI:
    10.1038/s41598-025-92970-1
  • 发表时间:
    2025-03-10
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Olamide Olayinka;Hannah Ryu;Xiaowei Wang;Asrar B. Malik;Hyun Min Jung
  • 通讯作者:
    Hyun Min Jung
The GTPase Rab1 Is Required for NLRP3 Inflammasome Activation and Inflammatory Lung Injury
GTPase Rab1 是 NLRP3 炎症小体激活和炎症性肺损伤所必需的
  • DOI:
    10.4049/jimmunol.1800777
  • 发表时间:
    2018-11
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Yuehui Zhang;Lijun Wang;Yang Lv;Chunling Jiang;Guangyu Wu;R;al O. Dull;Richard D. Minshall;Asrar B. Malik;Guochang Hu
  • 通讯作者:
    Guochang Hu

Asrar B. Malik的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Asrar B. Malik', 18)}}的其他基金

iPSC-Derived Vascularized Human Lung Organoids and Interaction Between Lung Endothelial Cells and Alveolar Epithelial Cells
iPSC 衍生的血管化人肺类器官以及肺内皮细胞和肺泡上皮细胞之间的相互作用
  • 批准号:
    10467249
  • 财政年份:
    2022
  • 资助金额:
    $ 57.46万
  • 项目类别:
Mechanisms and Treatment of SARS-CoV-2 induced Lung Endothelial Injury
SARS-CoV-2引起的肺内皮损伤的机制和治疗
  • 批准号:
    10559640
  • 财政年份:
    2022
  • 资助金额:
    $ 57.46万
  • 项目类别:
iPSC-Derived Vascularized Human Lung Organoids and Interaction Between Lung Endothelial Cells and Alveolar Epithelial Cells
iPSC 衍生的血管化人肺类器官以及肺内皮细胞和肺泡上皮细胞之间的相互作用
  • 批准号:
    10673199
  • 财政年份:
    2022
  • 资助金额:
    $ 57.46万
  • 项目类别:
E3 Ubiquitin Ligase CHFR Regulates Lung Endothelial Barrier Integrity and Innate Immunity through Control of VE-cadherin Expression
E3 泛素连接酶 CHFR 通过控制 VE-钙粘蛋白表达来调节肺内皮屏障完整性和先天免疫
  • 批准号:
    10706515
  • 财政年份:
    2022
  • 资助金额:
    $ 57.46万
  • 项目类别:
E3 Ubiquitin Ligase CHFR Regulates Lung Endothelial Barrier Integrity and Innate Immunity through Control of VE-cadherin Expression
E3 泛素连接酶 CHFR 通过控制 VE-钙粘蛋白表达来调节肺内皮屏障完整性和先天免疫
  • 批准号:
    10494617
  • 财政年份:
    2022
  • 资助金额:
    $ 57.46万
  • 项目类别:
Mechanisms and Treatment of SARS-CoV-2 induced Lung Endothelial Injury
SARS-CoV-2引起的肺内皮损伤的机制和治疗
  • 批准号:
    10390863
  • 财政年份:
    2022
  • 资助金额:
    $ 57.46万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10491051
  • 财政年份:
    2021
  • 资助金额:
    $ 57.46万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10701924
  • 财政年份:
    2021
  • 资助金额:
    $ 57.46万
  • 项目类别:
Ion Flux Regulation of Macrophage Plasticity in Lung Injury and Repair
肺损伤与修复中巨噬细胞可塑性的离子通量调节
  • 批准号:
    10701929
  • 财政年份:
    2021
  • 资助金额:
    $ 57.46万
  • 项目类别:
Macrophage Plasticity in Inflammatory Lung Injury
炎症性肺损伤中的巨噬细胞可塑性
  • 批准号:
    10491049
  • 财政年份:
    2021
  • 资助金额:
    $ 57.46万
  • 项目类别:

相似海外基金

Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
  • 批准号:
    10648387
  • 财政年份:
    2023
  • 资助金额:
    $ 57.46万
  • 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
  • 批准号:
    10720687
  • 财政年份:
    2023
  • 资助金额:
    $ 57.46万
  • 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
  • 批准号:
    10719249
  • 财政年份:
    2023
  • 资助金额:
    $ 57.46万
  • 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
  • 批准号:
    10591804
  • 财政年份:
    2023
  • 资助金额:
    $ 57.46万
  • 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
  • 批准号:
    10741574
  • 财政年份:
    2023
  • 资助金额:
    $ 57.46万
  • 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
  • 批准号:
    23K07651
  • 财政年份:
    2023
  • 资助金额:
    $ 57.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
  • 批准号:
    10679944
  • 财政年份:
    2023
  • 资助金额:
    $ 57.46万
  • 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
  • 批准号:
    10575258
  • 财政年份:
    2023
  • 资助金额:
    $ 57.46万
  • 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
  • 批准号:
    10701207
  • 财政年份:
    2023
  • 资助金额:
    $ 57.46万
  • 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
  • 批准号:
    MR/Y000404/1
  • 财政年份:
    2023
  • 资助金额:
    $ 57.46万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了